Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term agonists. Found 17 abstracts

Galal Osman A, Elokely KM, Yadav VK, Carvalho P, Radwan M, Slade D, Gul W, Khan S, Dale OR, Husni AS, Klein ML, Cutler SJ, Ross SA, ElSohly MA. Bioactive products from singlet oxygen photooxygenation of cannabinoids. European journal of medicinal chemistry. 2018 Jan;143:983-96.
Hurwitz MD, Harris J, Sartor O, Xiao Y, Shayegan B, Sperduto PW, Badiozamani KR, Lawton CA, Horwitz EM, Michalski JM, Roof K, Beyer DC, Zhang Q, Sandler HM. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621. Cancer. 2017 Jul;123(13):2489-96.   PMCID: PMC5474197
Liu B, Tang L, Zhang X, Ma J, Sehgal M, Cheng J, Zhang X, Zhou Y, Du Y, Kulp J, Guo JT, Chang J. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists. Antiviral research. 2017 Nov;147:37-46.   PMCID: PMC5789800
Brailoiu GC, Deliu E, Console-Bram LM, Soboloff J, Abood ME, Unterwald EM, Brailoiu E. Cocaine inhibits store-operated Ca2+ entry in brain microvascular endothelial cells: critical role for sigma-1 receptors. Biochem J. 2016 Jan;473(1):1-5.   PMCID: PMC4679692
Finnberg NK, Gokare P, Navaraj A, Lang Kuhs KA, Cerniglia G, Yagita H, Takeda K, Motoyama N, El-Deiry WS. Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity. Cancer Res. 2016 Feb;76(3):700-12.   PMCID: PMC5001853
Lounsbury N, Mateo G, Jones B, Papaiahgari S, Thimmulappa RK, Teijaro C, Gordon J, Korzekwa K, Ye M, Allaway G, Abou-Gharbia M, Biswal S, Childers W. Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy. Bioorganic & medicinal chemistry. 2015 Sep;23(17):5352-9.
Moore HC, Unger JM, Phillips KA, Boyle F, Hitre E, Porter D, Francis PA, Goldstein LJ, Gomez HL, Vallejos CS, Partridge AH, Dakhil SR, Garcia AA, Gralow J, Lombard JM, Forbes JF, Martino S, Barlow WE, Fabian CJ, Minasian L, Meyskens FL, Gelber RD, Hortobagyi GN, Albain KS. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. The New England journal of medicine. 2015 Mar 05;372(10):923-32.   PMCID: 4405231
Zhang Y, Zhao J, Li R, Lau WB, Yuan YX, Liang B, Li R, Gao EH, Koch WJ, Ma XL, Wang YJ. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings. Am J Physiol Endocrinol Metab. 2015 Aug;309(3):E275-82.   PMCID: PMC4525114
Chisari FV, Mason WS, Seeger C. Virology. Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA". Science (New York, NY). 2014 Jun 13;344(6189):1237.   PMCID: Comment
Cheung M, Testa JR. Diverse mechanisms of AKT pathway activation in human malignancy. Curr Cancer Drug Targets. 2013 Mar;13(3):234-44.   PMCID: PMC3678724
Maximov PY, Myers CB, Curpan RF, Lewis-Wambi JS, Jordan VC. Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifen. Journal of medicinal chemistry. 2010 Apr 22;53(8):3273-83.   PMCID: PMC2867604
Borghaei H, Smith MR, Campbell KS. Immunotherapy of cancer. European journal of pharmacology. 2009 Dec 25;625(1-3):41-54.   PMCID: PMC2783916
Wong YN, Freedland SJ, Egleston B, Vapiwala N, Uzzo R, Armstrong K. The role of primary androgen deprivation therapy in localized prostate cancer. Eur Urol. 2009 Oct;56(4):609-16.   PMCID: PMC2791191
Held-Warmkessel J. Caring for a patient with metastatic prostate cancer. Nursing. 2008 Jun;38(6):52-6.
Badawi AF, Badr MZ. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). Int J Oncol. 2002 Jun;20(6):1109-22.
Held-Warmkessel J. What your patient needs to know about prostate cancer. Nursing. 2002 Dec;32(12):36-42; quiz N232.
Haas N, Roth B, Garay C, Yeslow G, Entmacher M, Weinstein A, Rogatko A, Babb J, Minnitti C, Flinker D, Gillon T, Hudes G. Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer. Urology. 2001 Jul;58(1):59-64.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term agonists

agonists drug effects therapeutic use Male pharmacology metabolism therapy Female methods Prostatic Neoplasms Gonadotropin-Releasing Hormone chemistry Mice Antineoplastic Agents drug therapy Breast Neoplasms Human Tumor Cell Line Disease-Free Survival Prostatectomy Androgen Antagonists chemically induced Aged administration & dosage Signal Transduction genetics prevention & control Oral Administration Prostate-Specific Antigen Antiviral Agents Cell Proliferation 80 and over Aged Oxidative Stress Neoplasm Staging antagonists & inhibitors Adult Gonadorelin Middle Age chemical synthesis immunology Middle Aged Apoptosis Antineoplastic Combined Chemotherapy Protocols Neoplasms Monoclonal Antibodies blood Transcription Factors diagnosis Treatment Outcome Adenocarcinoma Mass Screening adverse effects physiology Cultured Cells Oncologic Nursing Transgenic Mice pathology mortality Risk Factors Proto-Oncogene Proteins c-akt Microvessels derivatives Intravenous Infusions Innate immune diabetes Empathy Anti-Bacterial Agents Prostaglandin-Endoperoxide Synthase Nucleotidyltransferases Myocardial Reperfusion Injury NF-E2-Related Factor 2 Antioxidants Innate Immunity Microbial Sensitivity Tests Lethal Dose 50 Hypoglycemic Agents Dendritic Cells Mutation Estrogen Antagonists Orchiectomy Kallikreins Enzyme Activation Nitriles Toll-Like Receptors Species Specificity Radioimmunotherapy epidemiology Pregnancy Rate calcium high risk Interferon Inducers Photooxygenation Disease Progression Rats Cocaine surgery Multivariate Analysis Tosyl Compounds Molecular Models Adiponectin Receptors Adjuvant Chemoradiotherapy Cell Line Binding Sites Fungi X-Ray Crystallography Hepatocytes Piperazines Proportional Hazards Models Taxoids Gastrointestinal Diseases Piperidines Animal Disease Models Anilides postprostatectomy Antiprotozoal Agents chemotherapy Biological Models Palliative Care Prostaglandins Paclitaxel Premenopause Keap1 Intensity-Modulated Radiotherapy etiology Edema Cannabinoid Receptor-CB2 Patient Education as Topic Structure-Activity Relationship Heme Oxygenase-1 Non-Steroidal Anti-Inflammatory Agents cytology Viral DNA Social Support Psychological Adaptation Circular DNA Stereoisomerism Plasmodium falciparum adverse Myocardial Ischemia Isoenzymes store-operated calcium entry physiopathology US Gov't Support-PHS Radiotherapy Hepatitis B virus Cell Death reperfusion injury Cell Survival effects Anticancer
Last updated on Saturday, August 15, 2020